ATE174603T1 - Faktor iia inhibitoren - Google Patents

Faktor iia inhibitoren

Info

Publication number
ATE174603T1
ATE174603T1 AT92903870T AT92903870T ATE174603T1 AT E174603 T1 ATE174603 T1 AT E174603T1 AT 92903870 T AT92903870 T AT 92903870T AT 92903870 T AT92903870 T AT 92903870T AT E174603 T1 ATE174603 T1 AT E174603T1
Authority
AT
Austria
Prior art keywords
group
present
nle
nal
ile
Prior art date
Application number
AT92903870T
Other languages
English (en)
Inventor
Nispen Johannes Wilhelmus Van
Henricus Carl Joseph Ottenheym
Jacobus Albertus Maria Peters
Arie Visser
Willemientje Jetten
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE174603T1 publication Critical patent/ATE174603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92903870T 1991-02-04 1992-02-04 Faktor iia inhibitoren ATE174603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200201 1991-02-04

Publications (1)

Publication Number Publication Date
ATE174603T1 true ATE174603T1 (de) 1999-01-15

Family

ID=8207509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903870T ATE174603T1 (de) 1991-02-04 1992-02-04 Faktor iia inhibitoren

Country Status (11)

Country Link
US (1) US5719128A (de)
EP (2) EP0498508A1 (de)
JP (1) JPH06505001A (de)
KR (1) KR930703348A (de)
AT (1) ATE174603T1 (de)
AU (1) AU656947B2 (de)
CA (1) CA2101331A1 (de)
DE (1) DE69227895D1 (de)
FI (1) FI933454A0 (de)
NO (1) NO932769D0 (de)
WO (1) WO1992013877A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
JPH09508355A (ja) * 1993-12-09 1997-08-26 チバ−ガイギー アクチェンゲゼルシャフト 組合せ化合物ライブラリーの製法
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
WO2003022873A1 (de) * 2001-09-10 2003-03-20 Novel Science International Gmbh Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
WO2017009358A1 (en) * 2015-07-13 2017-01-19 Universiteit Gent Hydrogel-forming peptides
EP3419642B1 (de) 2016-02-16 2023-10-04 Vrije Universiteit Brussel Hydrogelformende zusammensetzung enthaltend einen peptidhydrogelator zur kontrollierten freisetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318904A (en) * 1980-04-25 1982-03-09 Research Corporation Peptide affinity labels for thrombin and other trypsin-like proteases
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
IT251700Y1 (it) * 2000-01-21 2004-01-20 Lotto Sport Italia Spa Struttura di suola

Also Published As

Publication number Publication date
AU1193392A (en) 1992-09-07
EP0570428A1 (de) 1993-11-24
EP0570428B1 (de) 1998-12-16
EP0498508A1 (de) 1992-08-12
JPH06505001A (ja) 1994-06-09
FI933454L (fi) 1993-08-03
NO932769L (no) 1993-08-03
FI933454A7 (fi) 1993-08-03
WO1992013877A1 (en) 1992-08-20
US5719128A (en) 1998-02-17
DE69227895D1 (de) 1999-01-28
KR930703348A (ko) 1993-11-29
FI933454A0 (fi) 1993-08-03
CA2101331A1 (en) 1992-08-05
NO932769D0 (no) 1993-08-03
AU656947B2 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
IE820465L (en) Peptides
CA2272990A1 (en) Heptapeptide oxytocin analogues
ATE194846T1 (de) Zyklische antimikrobielle peptide und deren herstellung
PE109698A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
DE3881592D1 (de) Lhrh antagonisten, deren herstellung und entsprechende pharmazeutische zubereitungen.
DE69227895D1 (de) FAKTOR IIa INHIBITOREN
KR910014395A (ko) 신규 화합물
KR900016238A (ko) 신규 화합물
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
EP0206090A3 (de) Peptid-Renin-Inhibitoren
KR880011198A (ko) 사이클릭 펩타이드 및 이의 제조방법
KR850006941A (ko) 데스-프로린 바조프레신 길항제의 제조방법
KR850002834A (ko) 염기성 헵타 펩타이드 바조프레신 길항근의 제조방법
ATE6148T1 (de) Hexapeptide, deren herstellung, deren anwendung in arzneimitteln und sie enthaltende zusammensetzungen.
EP0361977A3 (de) Peptide mit T-Zellensuppressor-Wirksamkeit
ATE70454T1 (de) Vincristin enthaltendes produkt.
ATE46347T1 (de) Immunostimulierende peptide.
IE38320L (en) Nor-morphines and nor-codeines
EP0375058A3 (de) Retro-Inverso-Thrymopentin-Analoge, Verfahren zu deren Herstellung und deren Verwendung für die Zubereitung von pharmazeutischen Zusammensetzungen
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
JPS5772950A (en) Tetrapeptide derivative, its preparation and analgesic agent
JPS6450896A (en) Contraction suppressing peptide
TH2217A (th) กรรมวิธีในการเตรียมเฮพทาเพบไทด์ที่มีฤทธิ์เป็นด่างและต่อต้านวาโซเพรสซิน
MX9603149A (es) Derivados de camptotecina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties